Zydus Cadila Gets US Regulator's Nod For Drug, Shares Jump 2%

New Delhi: Zydus Cadila has received approval from the US Food and Drug Administration (USFDA) to market aspirin and extended release dipyridamole capsules, used to prevent excessive blood clotting and reduce the risk of strokes. After the announcement, shares of the company's listed entity Cadila Healthcare rose by over two per cent to Rs 510 apiece on the Bombay Stock Exchange (BSE). The company has received final approval from the...